Cary Street Partners Investment Advisory LLC Sarepta Therapeutics, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$152 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $15,785 - $19,032	154 Added 154.0%	254 $30,000
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $10,086 - $13,213	100 New	100 $12,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $18,834 - $26,811	-150 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $19,068 - $25,851	150 New	150 $21,000

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

85.3M

Call Options Held

1.55M

Put Options Held

1.35M

Black Rock Inc. New York, NY

10.3M
Shares

$659 Million
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.09M
Shares

$580 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

8.7M
Shares

$555 Million
0.21% of portfolio
Janus Henderson Group PLC London, X0

4.33M
Shares

$276 Million
0.28% of portfolio
State Street Corp Boston, MA

4.07M
Shares

$260 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $5.59B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account